As expected, IκBα expression decreased in COPD and increased in GAE treatment groups, while p-IκBα and IKKβ expression increased in COPD and decreased in GAE treatment groups (p < 0.05 or p < 0.01), respectively. Here, NFKBIA is linked to chronic obstructive pulmonary disease.